Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 12.71% is 24% above its 5-year average of 10.22%, near the high end of its 5-year range (5.95%–14.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.31% below its 12-month average of 13.42%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.71%.
DEBT TO ASSETS RATIO
12.71%
DEBT TO ASSETS RATIO AVG TTM
13.42%
DEBT TO ASSETS RATIO AVG 3Y
11.91%
DEBT TO ASSETS RATIO AVG 5Y
10.22%
DEBT TO ASSETS RATIO AVG 10Y
7.08%
DEBT TO ASSETS RATIO AVG 15Y
5.97%
DEBT TO ASSETS RATIO AVG 20Y
6.16%
CURRENT VS TTM AVG
-5.31%
CURRENT VS 3Y AVG
+6.66%
CURRENT VS 5Y AVG
+24.40%
CURRENT VS 10Y AVG
+79.50%
CURRENT VS 15Y AVG
+112.69%
CURRENT VS 20Y AVG
+106.14%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
+12607.52%
vs the sector median at left
Anika Therapeutics, Inc.
Market Cap
$255.95M
Debt to Assets Ratio
12.71%
TTM Avg
13.42%
3Y Avg
11.91%
5Y Avg
10.22%
Market Cap
$255.42M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.91M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250.09M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.16M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.47M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | $255.95M | 12.71% | 13.42% | 11.91% | 10.22% |
| Century Therapeutics, Inc. (IPSC)vs › | $255.42M | 0.12% | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.98M | 0.03% | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $259.91M | 0.10% | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.09M | 0.03% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | 0.01% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $246.20M | 0.04% | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.47M | 0.00% | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.91M | 0.68% | N/A | N/A | N/A |
Debt/Assets
12.7%
Debt/Equity
0.17
Current Ratio
4.48
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 12.71% |
| 2026-03-31 | 14.35% |
| 2025-12-31 | 13.80% |
| 2025-09-30 | 12.94% |
| 2025-06-30 | 13.31% |
| 2025-03-31 | 13.35% |
| 2024-12-31 | 12.79% |
| 2024-09-30 | 11.90% |
| 2024-06-30 | 10.69% |
| 2024-03-31 | 10.80% |
| 2023-12-31 | 10.25% |
| 2023-09-30 | 8.93% |
| 2023-06-30 | 9.08% |
| 2023-03-31 | 8.96% |
| 2022-12-31 | 8.85% |
| 2022-09-30 | 8.94% |
| 2022-06-30 | 8.93% |
| 2022-03-31 | 5.98% |
| 2021-12-31 | 6.03% |
| 2021-09-30 | 6.00% |
| 2021-06-30 | 5.95% |
| 2021-03-31 | 6.12% |
| 2020-12-31 | 6.14% |
| 2020-09-30 | 11.47% |
| 2020-06-30 | 16.59% |
| 2020-03-31 | 5.87% |
| 2019-12-31 | 6.81% |
| 2019-09-30 | 7.11% |
| 2019-06-30 | 8.03% |
| 2019-03-31 | 7.60% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 5.35% |
| 2013-06-30 | 5.93% |
| 2013-03-31 | 6.51% |
| 2012-12-31 | 6.76% |
| 2012-09-30 | 7.41% |
| 2012-06-30 | 7.63% |
| 2012-03-31 | 8.11% |
| 2011-12-31 | 8.43% |
| 2011-09-30 | 8.94% |
| 2011-06-30 | 9.13% |
| 2011-03-31 | 9.63% |
| 2010-12-31 | 9.93% |
| 2010-09-30 | 10.17% |
| 2010-06-30 | 10.96% |
| 2010-03-31 | 11.00% |
| 2009-12-31 | 11.02% |
| 2009-09-30 | 15.34% |
| 2009-06-30 | 15.84% |
| 2009-03-31 | 16.36% |
| 2008-12-31 | 1.67% |
| 2008-09-30 | 9.06% |
| 2008-06-30 | 9.06% |
| 2008-03-31 | 4.84% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
